A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study by Silva, Nackle J et al.
ORAL PRESENTATION Open Access
A systematic review for sudden cardiac death in
hypertrophic cardiomyopathy patients with
myocardial fibrosis: a CMR LGE study
Nackle J Silva
*, Antonio T Paladino, Mark Doyle, Sahadev T Reddy, Geetha Rayarao, June Yamrozik,
Ronald B Williams, Diane A Vido, Robert W Biederman
From 15th Annual SCMR Scientific Sessions
Orlando, FL, USA. 2-5 February 2012
Summary
To our knowledge this represent the first attempt at a
formal meta-analysis to demonstrate that SCD is pre-
dicted by LGE, not just VT/VF.
Background
Hypertrophic cardiomyopathy (HCM) is a genetic dis-
ease that affects the cardiac sarcomere, resulting in
myocardial hypertrophy and disarray. Affected patients
have a predisposition for malignant ventricular tachyar-
rhythmias and, consequently, sudden cardiac death
(SCD). In single center studies, late gadolinium
enhancement (LGE) defined fibrosis has been linked to
the substrate for VT/VF. However, despite innumerable
investigations, SCD has not been definitely attributable
to LGE. Explanations for this are believed to be related
to insufficient statistical power.
Methods
We performed an electronic search of MEDLINE,
PubMED and CMR abstracts for original data published
or presented between Jan 01 - Mar 11. Key search
terms: HCM, LV fibrosis, SCD and LGE. Studies were
screened for eligibility based on inclusion criteria: refer-
ral for CMR exam with LGE for HCM; and follow-up
for incidence of VT/VF and SCD. Relevant studies were
summarized and the following data were abstracted:
socio-demographic information; study design; incidence
of reported VT/VF; SCD. Categorical variables were
evaluated between pt groups via Chi-square test.
Results
A total of 64 studies were initially identified. Of these, 4
(6.3%) were identified and included (n=1,063 pts, range
202 to 424). Three prospective and 1 retrospective studies
were included. LGE was detected in 59.6% of pts. Mean
follow-up was 43±14mo. Age 22-90 yrs (63% male). As
expected, the presence of myocardial fibrosis was asso-
ciated with VT/VF (c2=6.5, p<0.05; OR 9.0 (95% CI 1.2 to
68.7). Moreover, myocardial fibrosis strongly predicted
SCD (c2=6.6, p<0.05; OR 3.3 (95% CI 1.2 to 9.7).
Conclusions
Despite single center CMR studies, LGE has consistently
predicted VT/VF while prediction of SCD has remained
paradoxically unlinked. Although the lack of studies
meeting our criteria limited our ability to perform a
comprehensive meta-analysis, we have been able to
demonstrate for the first time that LGE-defined fibrosis
is a predictor of SCD in patients with HCM. This obser-
vation now demands a multi-center RCT for confirma-
tion but supports the consideration of a primary
indication of AICD implantation in HCM with LGE.
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